Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

COVID-19: Answering the Questions, Part 3

Source: COVID-19 Comprehensive Resource Center

In Part 3 of this ongoing 12-part COVID-19 series, listen to a brief update on the latest incidence trends and a concise guide to the management of mild and moderate disease, followed by answers to critical clinician questions on COVID-19 transmission, diagnosis, and management from frontline provider Sharon Lewin, AO, FRACP, PhD, FAAHMS.

Sharon R. Lewin, AO, FRACP, FAHMS
Released: June 29, 2020

Podcast Notes

In this episode, Part 3 of an ongoing 12-part COVID-19 series, Sharon Lewin, AO, FRACP, PhD, FAAHMS, provides a brief update on the latest incidence trends and a concise guide to the management of mild and moderate disease. After the update, Dr. Lewin answers critical clinician questions on COVID-19 transmission, diagnosis, and management.

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program: https://www.clinicaloptions.com/infectious-disease/programs/covid19-resources

Information on this Educational Activity

Faculty

Sharon R. Lewin, AO, FRACP, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
Faculty Medicine Dentistry and Health Sciences
University of Melbourne and Royal Melbourne Hospital
Consultant Infectious Diseases Physician
Department of Infectious Diseases
Royal Melbourne Hospital and Alfred Hospital
Melbourne, Australia

Sharon Lewin, AO, FRACP, PhD, FAAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.

Staff

Jennifer Blanchette, PhD

Senior Scientific Director

Jennifer Blanchette, PhD, has no relevant conflicts of interest to report.
Edward King, MA

Executive Vice President

Edward King, MA, has no relevant conflicts of interest to report.
Tiffany Hensley-McBain, PhD

Scientific Director

Tiffany Hensley-McBain, PhD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by
Gilead Sciences, Inc.

Related Content

Download free slides reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis, symptoms, management, and treatment

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Sharon R. Lewin, AO, FRACP, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: January 19, 2021

Dr. Roger Paredes reviews safety and efficacy data on COVID-19 vaccines and considerations for vaccine rollout from Clinical Care Options (CCO)

Roger Paredes, MD, PhD Released: January 7, 2021

Vikramjit Mukherjee, MD, provides a brief update on COVID-19 and answers clinician questions in the CCO Infectious Disease podcast

Vikramjit Mukherjee, MD Released: December 31, 2020

Review frequently asked questions and answers from expert CCO faculty on rapidly evolving data on COVID-19 vaccines and immunity

Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Released: December 29, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue